NCT06789328View on ClinicalTrials.gov

The Effect of Dexamethasone Administration Route on Pain and Inflammatory Response in PENG Block for Total Hip Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

June 30, 2025

Study Completion Date

July 11, 2025

Conditions
Osteoarthritis, HipHip Pain ChronicHip ArthropathyHip Arthritis
Interventions
DRUG

perineural Dexamethasone 4mg

PENG block with 20ml 0.2% ropivacaine + 4mg perineural Dexamethasone

DRUG

intravenous Dexamethsone 4mg

PENG block with 20ml 0.2% ropivacaine + 4mg intravenous Dexamethasone

Trial Locations (1)

60-701

Poznan University of Medical Sciences, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER

NCT06789328 - The Effect of Dexamethasone Administration Route on Pain and Inflammatory Response in PENG Block for Total Hip Arthroplasty | Biotech Hunter | Biotech Hunter